KBG Corp, formerly Korea Bio-Gen Co Ltd, is a Korea-based company mainly engaged in silicone materials business. The Company manufactures and sells silicone materials such as silane monomers, silicone resins and polymers, and silicone fusion materials. The Company also produces and sell fine chemicals and bio products.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
30/09/26	₩2,670.00	-0.74%	7,713
29/09/26	₩2,690.00	-2.18%	16,777
28/09/26	₩2,750.00	-0.72%	5,243
23/09/26	₩2,770.00	+0.91%	3,036
22/09/26	₩2,745.00	-0.18%	3,543

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 30/09/2026			5-day change	1st Jan Change
2,670.00 ^KRW	-0.74%		-3.61%	-39.32%

11-05	KBG Corp. announces Annual dividend, payable on April 10, 2026	CI
10/07/24	KBG Corp. completed the acquisition of Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD.	CI

Market Cap	23.23B 17.15M 15.1M 14.31M 12.92M 24.34M 1.64B 24.66M 171M 65.87M 841M 64.39M 62.98M 2.69B	P/E 2024	10.8x	P/E 2025	14.8x
Enterprise Value	6.49B 4.79M 4.22M 4M 3.61M 6.8M 459M 6.89M 47.82M 18.4M 235M 17.99M 17.59M 753M	EV / Sales 2024	1.22x	EV / Sales 2025	0.9x
Free-Float	63.24%	Yield 2024 *	-	Yield 2025	-

11-05	KBG Corp. announces Annual dividend, payable on April 10, 2026	CI
10/07/24	KBG Corp. completed the acquisition of Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD.	CI
27/06/24	KBG Corp. agreed to acquire Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD for KRW 8.3 billion.	CI
12/05/23	KBG Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
11/05/21	Korea Bio-Gen Co.,Ltd announced that it has received KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor	CI
09/05/21	Korea Bio-Gen Co.,Ltd announced that it expects to receive KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor	CI
16/09/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
16/09/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
15/09/20	Korea Bio-Gen Co.,Ltd's Equity Buyback announced on March 17, 2020, has expired with 79,364 shares, representing 0.98% for KRW 318.89 million.	CI
17/06/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
17/03/20	Korea Bio-Gen Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	CI
16/03/20	Korea Bio-Gen Co.,Ltd authorizes a Buyback Plan.	CI
30/07/19	Korea Bio-Gen Co.,Ltd has completed an IPO in the amount of KRW 10.707 billion.	CI

1 day	-0.74%
1 week	-3.61%
1 month	-5.65%
3 months	-7.77%
6 months	-36.65%
Current year	-39.32%

KBG Corp. Share Price

Stocks

A318000

KR7318000007

Specialty Chemicals

Valuation: KBG Corp.

Chart: KBG Corp.

Latest news: KBG Corp.

Quotes and Performance

Price Extremes

Managers and Directors: KBG Corp.

Other Specialty Chemicals

Financials

Company Profile

Quotes

1 week	2,645	2,780
1 month	2,645	2,920
Current year	2,545	4,830
1 year	2,545	6,160
3 years	2,545	10,210
5 years	2,545	21,150
10 years	2,545	21,150

Manager	Title	Age	Since
Sam-Yeol Pu CEO	Chief Executive Officer	40	23/03/2022
Tae-Kyun Boo SAM	Sales & Marketing	60	29/02/2020
Sang-Ho Do AUD	Comptroller/Controller/Auditor	67	-

Director	Title	Age	Since
Tae-Ung Pu CHM	Chairman	68	-
Sam-Yeol Pu BRD	Director/Board Member	40	23/03/2022
Kyung Choi BRD	Director/Board Member	68	24/03/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KBG CORP.	-0.74%	-3.61%	-44.89%	-69.86%	17.15M
ECOLAB INC.	-1.18%	-0.77%	+0.26%	+62.09%	76.97B
GIVAUDAN SA	-0.59%	-0.82%	+5.07%	+14.90%	37.73B
SIKA AG	-1.78%	-1.32%	+0.87%	-21.87%	35.38B
HENKEL AG & CO. KGAA	-1.41%	-2.89%	+4.32%	+6.51%	31.95B
NOVONESIS A/S	-0.58%	-6.14%	+5.16%	+50.29%	29.7B
FUJIFILM HOLDINGS CORPORATION	+1.34%	+0.71%	-6.32%	+17.69%	25.47B
EMS-CHEMIE HOLDING AG	-0.24%	-1.22%	+43.68%	+32.22%	22.97B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-1.83%	-6.09%	+50.93%	+8.71%	18.53B
DUPONT DE NEMOURS, INC.	-0.18%	-0.76%	-44.42%	-41.95%	17.54B
Average	-0.74%	-1.73%	+1.47%	+5.87%	29.63B
Weighted average by Cap.	-0.84%	-1.34%	+5.20%	+23.24%

	2024	2025
Net sales	24.92B 18.39M 16.2M 15.35M 13.85M 26.11M 1.76B 26.45M 184M 70.66M 902M 69.07M 67.56M 2.89B	23.92B 17.66M 15.55M 14.73M 13.3M 25.07M 1.69B 25.39M 176M 67.84M 866M 66.31M 64.86M 2.78B
Net income	3.77B 2.78M 2.45M 2.32M 2.09M 3.95M 267M 4M 27.76M 10.68M 136M 10.44M 10.21M 437M	2.59B 1.91M 1.68M 1.6M 1.44M 2.72M 183M 2.75M 19.1M 7.35M 93.79M 7.18M 7.03M 301M
Net Debt	-10.55B -7.79M -6.86M -6.5M -5.87M -11.06M -747M -11.2M -77.78M -29.93M -382M -29.26M -28.62M -1.22B	-16.74B -12.36M -10.88M -10.31M -9.31M -17.54M -1.18B -17.77M -123M -47.47M -606M -46.4M -45.39M -1.94B